Amgen Inc drugs

10 results
  • bkemv - eculizumab - aeeb injection, solution, concentrate

    (Eculizumab-Aeeb)
    Amgen Inc
    BKEMV is a complement inhibitor indicated for paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis, atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy, and generalized myasthenia gravis (gMG) in AChR antibody-positive adults. Not indicated for STEC-HUS.
  • imdelltra

    (Tarlatamab-Dlle)
    Amgen Inc
    Imdelltra is indicated for adults with extensive-stage small cell lung cancer (ES-SCLC) whose disease has progressed on or after platinum-based chemotherapy.
  • imlygic - talimogene laherparepvec injection, suspension

    (Talimogene Laherparepvec)
    Amgen Inc
    IMLYGIC is an oncolytic viral therapy for local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in melanoma patients who have had a recurrence after initial surgery. It has not been shown to improve overall survival or affect visceral metastases.
  • lumakras - sotorasib tablet, coated

    (Sotorasib)
    Amgen Inc
    Lumakras treats adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (after at least one prior therapy) and KRAS G12C-mutated metastatic colorectal cancer (combined with panitumumab, after prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy).
  • otezla - apremilast tablet, film coated

    (Apremilast)
    Amgen Inc
    Otezla treats active psoriatic arthritis and plaque psoriasis in adults and children 6+ years old (min 20 kg). Also indicated for oral ulcers associated with Behçet's Disease in adults. Otezla XR requires minimum 50 kg for pediatric patients.
  • sensipar - cinacalcet hydrochloride tablet, coated

    (Cinacalcet Hydrochloride)
    Amgen Inc
    Sensipar treats secondary hyperparathyroidism in adult chronic kidney disease patients on dialysis, and hypercalcemia in adults with parathyroid carcinoma or primary hyperparathyroidism unable to undergo parathyroidectomy. Not indicated for CKD patients not on dialysis.
  • tezspire - tezepelumab - ekko injection, solution

    (Tezepelumab-Ekko)
    Amgen Inc
    Tezspire is indicated as add-on maintenance treatment for adults and patients aged 12 and older with severe asthma, and for inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP). Not for relief of acute bronchospasm or status asthmaticus.